首页> 外文会议>IEEE International Conference on Bioinformatics and Bioengineering >Global fitting and parameter identifiability for amyloid-β aggregation with competing pathways
【24h】

Global fitting and parameter identifiability for amyloid-β aggregation with competing pathways

机译:竞争途径淀粉样蛋白β聚集的全局拟合和参数可辨率性

获取原文

摘要

Aggregation of the amyloid-$eta$(A$eta$) protein has been implicated in Alzheimer’s disease (AD). Since, low molecular weight A$eta$ aggregates are hypothesized to serve as the primary toxic species in AD pathogenesis, significant research has been conducted to understand the mechanistic details of the aggregation process. We previously demonstrated that heterotypic interactions between A$eta$ and fatty acids (FAs) can lead to competing pathways of A$eta$ aggregation, termed as the off-pathway; this off-pathway kinetics can also be modulated by FA concentrations as captured by mass action models. We employed ensemble kinetics simulations which uses a system of Ordinary Differential Equations to model the competing on-and off-pathways of $Aeta$ aggregation that were trained and validated by biophysical experiments. However, these models had several rate constants, treated as free parameters to be estimated, which resulted in over-fitting of the model. Hence, in this paper, we present a global fitting based method to accurately identify the rate constants involved in the complex competing pathway model of $Aeta$ aggregation. We additionally employ detailed parameter identifiability tests for uncertainty quantification using the profile likelihood method. Since, the emergence of off-or on-pathway aggregates are typically controlled by a narrow set of rate constants, it is imperative to rigorously identify the proper rate constants involved in these pathways. These rate constants serve as a basis for future experiments on modulating the aggregation pathways to populate a particular possibly less toxic oligomeric species. The obtained rate constants also motivate new biophysical experiments to better understand the mechanisms of amyloid aggregation in other neurodegenerative diseases.
机译:淀粉样蛋白 - $ β$($ β$)蛋白的聚集在阿尔茨海默病(广告)中涉及。由于低分子量A $ β$综合被假设以作为Ad发病机制中的主要有毒物种,已经进行了显着的研究以了解聚集过程的机制细节。我们之前证明,$ β$和脂肪酸(FAS)之间的异型相互作用可以导致$ β$汇总的竞争途径,被称为偏离途径;这种偏离途径动力学也可以通过大规模行动模型捕获的FA浓度来调节。我们使用了使用普通微分方程系统的集合动力学模拟,以通过生物物理实验培训和验证的$ a beta $汇总的竞争和偏离路径。然而,这些模型具有几个速率常数,被视为估计的自由参数,导致模型过度拟合。因此,在本文中,我们介绍了一种基于全局拟合的方法,以准确识别$ a beta $汇总的复杂竞争路径模型中涉及的速率常数。我们另外使用简档似然方法使用详细的参数标识测试来进行不确定性量化。由于,途径聚集体的出现通常由狭窄的速率常数控制,因此必须严格识别这些途径中涉及的适当速率常数。这些速率常数是未来试验在调节聚集途径的实验的基础上,以填充特定可能更少有毒的低聚物质。所得速率常数还促进新的生物物理实验,以更好地了解其他神经变性疾病中淀粉样蛋白聚集的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号